Targeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other chronic inflammatory diseases

Project Information

REPROGRAM

Grant agreement ID: 667837

DOI 10.3030/667837

Closed project

EC signature date 4 December 2015

Start date 1 January 2016

End date 31 December 2019

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 6 000 000,00

EU contribution € 5 250 000,00

Coordinated by

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM
Netherlands

• New therapeutic potential for chronic inflammatory diseases
  EN